ERBB2 and breast cancer: The significant discriminatory improvements of the lifestyle/familial-expanded AI risk model over the imaging-only AI risk model ranged from 2.3–4.3 percentage points for screen-detected, symptomatic, invasive, ER-, PR-, HER2-positive, and stage 2 or later breast cancers (Figure 3, Table A3).